0.019713
0.011381
0.000000
0.000000
0.022763
0.000000
0.000000
0.000000
0.003724
0.00000
0.00000
0.00000
Pace, H.C.
Garrison, P.N.
Barnes, L.D.
Draganescu, A.
Rosler, A.
Blackburn, G.M.
Siprashvili, Z.
Croce, C.M.
Huebner, K.
Brenner, C.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
12
90.00
90.00
120.00
50.728
50.728
268.513
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C21 H29 N10 O14 P3 S
770.500
P1-P2-METHYLENE-P3-THIO-DIADENOSINE TRIPHOSPHATE
ADO-P-CH2-P-PS-ADO
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
95
5484
5489
10.1073/pnas.95.10.5484
9576908
Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit.
1998
UK
Protein Eng.
PRENE9
0859
0269-2139
10
1461
Purification and Crystallization of Complexes Modeling the Active State of the Fragile Histidine Triad Protein
1998
10.2210/pdb1fhi/pdb
pdb_00001fhi
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
98
1
CCD
1997-03-10
SI(111)
M
x-ray
1
0.918
1.0
F1
CHESS
0.918
SYNCHROTRON
CHESS BEAMLINE F1
16886.203
FRAGILE HISTIDINE TRIAD PROTEIN
3.6.1.29
1
man
polymer
770.500
P1-P2-METHYLENE-P3-THIO-DIADENOSINE TRIPHOSPHATE
1
syn
non-polymer
18.015
water
3
nat
water
FHIT
no
no
MSFRFGQHLIKPSVVFLKTELSFALVNRKPVVPGHVLVCPLRPVERFHDLRPDEVADLFQTTQRVGTVVEKHFHGTSLTF
SMQDGPEAGQTVKHVHVHVLPRKAGDFHRNDSIYEELQKHDKEDFPASWRSEEEMAAEAAALRVYFQ
MSFRFGQHLIKPSVVFLKTELSFALVNRKPVVPGHVLVCPLRPVERFHDLRPDEVADLFQTTQRVGTVVEKHFHGTSLTF
SMQDGPEAGQTVKHVHVHVLPRKAGDFHRNDSIYEELQKHDKEDFPASWRSEEEMAAEAAALRVYFQ
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
FHIT
9606
Homo sapiens
562
Escherichia coli
JM109/DE3/LACIQ
PSGA02
1
2.83
58.
VAPOR DIFFUSION, HANGING DROP
7.5
FHIT PROTEIN (13.4 MG/ML) WAS COCRYSTALLIZED WITH 2.5 MOLAR EQUIVALENTS OF IB2 BY MIXING WITH AN EQUAL VOLUME (2.5 - 4 MICROLITERS) OF 2 M AMMONIUM SULFATE, 4% PEG 400 0.1 M NA HEPES PH 7.5 ON A SILICONIZED COVERSLIP WHICH WAS SEALED OVER A 0.8 ML VOLUME OF THE SAME SOLUTION FOR 1 - 4 WEEKS AT ROOM TEMPERATURE., vapor diffusion - hanging drop
room temp
database_2
pdbx_database_status
pdbx_initial_refinement_model
struct_site
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
Refinement description
1
0
1998-06-17
1
1
2008-03-24
1
2
2011-07-13
1
3
2023-08-09
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
Y
BNL
1997-12-11
REL
REL
IB2
P1-P2-METHYLENE-P3-THIO-DIADENOSINE TRIPHOSPHATE
HOH
water
1FIT
PDB ENTRY 1FIT
PDB
experimental model
IB2
301
2
IB2
IB2
301
A
HOH
201
3
HOH
HOH
201
A
HOH
202
3
HOH
HOH
202
A
HOH
203
3
HOH
HOH
203
A
n
1
1
A
SER
2
n
2
SER
2
A
PHE
3
n
3
PHE
3
A
ARG
4
n
4
ARG
4
A
PHE
5
n
5
PHE
5
A
GLY
6
n
6
GLY
6
A
GLN
7
n
7
GLN
7
A
HIS
8
n
8
HIS
8
A
LEU
9
n
9
LEU
9
A
ILE
10
n
10
ILE
10
A
LYS
11
n
11
LYS
11
A
PRO
12
n
12
PRO
12
A
SER
13
n
13
SER
13
A
VAL
14
n
14
VAL
14
A
VAL
15
n
15
VAL
15
A
PHE
16
n
16
PHE
16
A
LEU
17
n
17
LEU
17
A
LYS
18
n
18
LYS
18
A
THR
19
n
19
THR
19
A
GLU
20
n
20
GLU
20
A
LEU
21
n
21
LEU
21
A
SER
22
n
22
SER
22
A
PHE
23
n
23
PHE
23
A
ALA
24
n
24
ALA
24
A
LEU
25
n
25
LEU
25
A
VAL
26
n
26
VAL
26
A
ASN
27
n
27
ASN
27
A
ARG
28
n
28
ARG
28
A
LYS
29
n
29
LYS
29
A
PRO
30
n
30
PRO
30
A
VAL
31
n
31
VAL
31
A
VAL
32
n
32
VAL
32
A
PRO
33
n
33
PRO
33
A
GLY
34
n
34
GLY
34
A
HIS
35
n
35
HIS
35
A
VAL
36
n
36
VAL
36
A
LEU
37
n
37
LEU
37
A
VAL
38
n
38
VAL
38
A
CYS
39
n
39
CYS
39
A
PRO
40
n
40
PRO
40
A
LEU
41
n
41
LEU
41
A
ARG
42
n
42
ARG
42
A
PRO
43
n
43
PRO
43
A
VAL
44
n
44
VAL
44
A
GLU
45
n
45
GLU
45
A
ARG
46
n
46
ARG
46
A
PHE
47
n
47
PHE
47
A
HIS
48
n
48
HIS
48
A
ASP
49
n
49
ASP
49
A
LEU
50
n
50
LEU
50
A
ARG
51
n
51
ARG
51
A
PRO
52
n
52
PRO
52
A
ASP
53
n
53
ASP
53
A
GLU
54
n
54
GLU
54
A
VAL
55
n
55
VAL
55
A
ALA
56
n
56
ALA
56
A
ASP
57
n
57
ASP
57
A
LEU
58
n
58
LEU
58
A
PHE
59
n
59
PHE
59
A
GLN
60
n
60
GLN
60
A
THR
61
n
61
THR
61
A
THR
62
n
62
THR
62
A
GLN
63
n
63
GLN
63
A
ARG
64
n
64
ARG
64
A
VAL
65
n
65
VAL
65
A
GLY
66
n
66
GLY
66
A
THR
67
n
67
THR
67
A
VAL
68
n
68
VAL
68
A
VAL
69
n
69
VAL
69
A
GLU
70
n
70
GLU
70
A
LYS
71
n
71
LYS
71
A
HIS
72
n
72
HIS
72
A
PHE
73
n
73
PHE
73
A
HIS
74
n
74
HIS
74
A
GLY
75
n
75
GLY
75
A
THR
76
n
76
THR
76
A
SER
77
n
77
SER
77
A
LEU
78
n
78
LEU
78
A
THR
79
n
79
THR
79
A
PHE
80
n
80
PHE
80
A
SER
81
n
81
SER
81
A
MET
82
n
82
MET
82
A
GLN
83
n
83
GLN
83
A
ASP
84
n
84
ASP
84
A
GLY
85
n
85
GLY
85
A
PRO
86
n
86
PRO
86
A
GLU
87
n
87
GLU
87
A
ALA
88
n
88
ALA
88
A
GLY
89
n
89
GLY
89
A
GLN
90
n
90
GLN
90
A
THR
91
n
91
THR
91
A
VAL
92
n
92
VAL
92
A
LYS
93
n
93
LYS
93
A
HIS
94
n
94
HIS
94
A
VAL
95
n
95
VAL
95
A
HIS
96
n
96
HIS
96
A
VAL
97
n
97
VAL
97
A
HIS
98
n
98
HIS
98
A
VAL
99
n
99
VAL
99
A
LEU
100
n
100
LEU
100
A
PRO
101
n
101
PRO
101
A
ARG
102
n
102
ARG
102
A
LYS
103
n
103
LYS
103
A
ALA
104
n
104
ALA
104
A
GLY
105
n
105
GLY
105
A
ASP
106
n
106
ASP
106
A
n
107
107
A
n
108
108
A
n
109
109
A
n
110
110
A
n
111
111
A
n
112
112
A
n
113
113
A
n
114
114
A
n
115
115
A
n
116
116
A
n
117
117
A
n
118
118
A
n
119
119
A
n
120
120
A
n
121
121
A
n
122
122
A
n
123
123
A
n
124
124
A
n
125
125
A
n
126
126
A
n
127
127
A
SER
128
n
128
SER
128
A
TRP
129
n
129
TRP
129
A
ARG
130
n
130
ARG
130
A
SER
131
n
131
SER
131
A
GLU
132
n
132
GLU
132
A
GLU
133
n
133
GLU
133
A
GLU
134
n
134
GLU
134
A
MET
135
n
135
MET
135
A
ALA
136
n
136
ALA
136
A
ALA
137
n
137
ALA
137
A
GLU
138
n
138
GLU
138
A
ALA
139
n
139
ALA
139
A
ALA
140
n
140
ALA
140
A
ALA
141
n
141
ALA
141
A
LEU
142
n
142
LEU
142
A
ARG
143
n
143
ARG
143
A
VAL
144
n
144
VAL
144
A
TYR
145
n
145
TYR
145
A
PHE
146
n
146
PHE
146
A
GLN
147
n
147
GLN
147
A
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
0.5000000000
0.8660254038
0.0000000000
0.8660254038
-0.5000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
12_555
x,x-y,-z+1/6
crystal symmetry operation
0.0000000000
0.0000000000
44.7521666667
A
O
SER
77
A
O
SER
77
A
N
ARG
102
A
N
ARG
102
A
O
VAL
97
A
O
VAL
97
A
N
VAL
38
A
N
VAL
38
A
O
LEU
37
A
O
LEU
37
A
N
LEU
25
A
N
LEU
25
A
O
ALA
24
A
O
ALA
24
A
N
LEU
17
A
N
LEU
17
1
A
CG
ASP
53
A
CG
ASP
53
1
Y
1
A
OD1
ASP
53
A
OD1
ASP
53
1
Y
1
A
OD2
ASP
53
A
OD2
ASP
53
1
Y
1
A
CG
ARG
64
A
CG
ARG
64
1
Y
1
A
CD
ARG
64
A
CD
ARG
64
1
Y
1
A
NE
ARG
64
A
NE
ARG
64
1
Y
1
A
CZ
ARG
64
A
CZ
ARG
64
1
Y
1
A
NH1
ARG
64
A
NH1
ARG
64
1
Y
1
A
NH2
ARG
64
A
NH2
ARG
64
1
Y
1
A
CG
GLU
87
A
CG
GLU
87
1
Y
1
A
CD
GLU
87
A
CD
GLU
87
1
Y
1
A
OE1
GLU
87
A
OE1
GLU
87
1
Y
1
A
OE2
GLU
87
A
OE2
GLU
87
1
Y
1
A
CG
GLU
133
A
CG
GLU
133
1
Y
1
A
CD
GLU
133
A
CD
GLU
133
1
Y
1
A
OE1
GLU
133
A
OE1
GLU
133
1
Y
1
A
OE2
GLU
133
A
OE2
GLU
133
1
Y
1
A
CG
GLU
134
A
CG
GLU
134
1
Y
1
A
CD
GLU
134
A
CD
GLU
134
1
Y
1
A
OE1
GLU
134
A
OE1
GLU
134
1
Y
1
A
OE2
GLU
134
A
OE2
GLU
134
1
Y
1
A
MET
1
A
MET
1
1
Y
1
A
PHE
107
A
PHE
107
1
Y
1
A
HIS
108
A
HIS
108
1
Y
1
A
ARG
109
A
ARG
109
1
Y
1
A
ASN
110
A
ASN
110
1
Y
1
A
ASP
111
A
ASP
111
1
Y
1
A
SER
112
A
SER
112
1
Y
1
A
ILE
113
A
ILE
113
1
Y
1
A
TYR
114
A
TYR
114
1
Y
1
A
GLU
115
A
GLU
115
1
Y
1
A
GLU
116
A
GLU
116
1
Y
1
A
LEU
117
A
LEU
117
1
Y
1
A
GLN
118
A
GLN
118
1
Y
1
A
LYS
119
A
LYS
119
1
Y
1
A
HIS
120
A
HIS
120
1
Y
1
A
ASP
121
A
ASP
121
1
Y
1
A
LYS
122
A
LYS
122
1
Y
1
A
GLU
123
A
GLU
123
1
Y
1
A
ASP
124
A
ASP
124
1
Y
1
A
PHE
125
A
PHE
125
1
Y
1
A
PRO
126
A
PRO
126
1
Y
1
A
ALA
127
A
ALA
127
1
Y
1
A
PHE
3
80.16
104.25
1
A
PHE
5
-161.62
81.93
1
A
THR
19
-108.04
-168.92
1
A
HIS
48
-52.28
-0.16
1
A
ARG
51
-54.66
178.95
1
A
GLU
54
-62.69
8.91
1
A
ARG
64
-60.74
-74.52
1
A
VAL
65
-33.62
-24.30
1
A
SER
77
165.68
167.15
1
A
SER
81
-164.38
116.97
1
A
HIS
96
-178.29
135.66
1
A
ALA
104
-44.66
160.48
PROTEIN_REP.PARAM
TOPHCSDX.PRO
PARHCSDX.PRO
TOPH19.PEP
WATER.PARAM
WATER2.TOPH
IB2.PAR
IB2.TOP
13.2
0.3140000
0.028
0.2410000
0.2410000
3.1
8.0
125
2535
5.0
61.
RANDOM
1000000.
0.
1
THROUGHOUT
3.5
REFINEMENT
PDB ENTRY 1FIT
3.1
8.0
3
1262
49
0
1210
0.011
1.56
27.2
0.854
0.5160000
0.156
0.2840000
3.23
11
157
8
7.0
33.
3.10
43.9
1FHI
2965
0.
0.0970000
1
10.2
68.3
3.1
3.21
8.5
0.0840000
39.1
model building
X-PLOR
3.851
refinement
X-PLOR
3.851
data reduction
DENZO
data scaling
SCALEPACK
phasing
X-PLOR
3.851
SUBSTRATE ANALOG (IB2) COMPLEX WITH THE FRAGILE HISTIDINE TRIAD PROTEIN, FHIT
1
N
N
2
N
N
3
N
N
A
PRO
12
A
PRO
12
HELX_P
A
VAL
14
A
VAL
14
5
1
3
A
PHE
47
A
PHE
47
HELX_P
A
ASP
49
A
ASP
49
5
2
3
A
ASP
53
A
ASP
53
HELX_P
A
THR
67
A
THR
67
1
3
15
A
VAL
69
A
VAL
69
HELX_P
A
HIS
72
A
HIS
72
1
4
4
A
GLU
132
A
GLU
132
HELX_P
A
TYR
145
A
TYR
145
1
5
14
NUCLEOTIDE-BINDING PROTEIN
NUCLEOTIDE-BINDING PROTEIN, CANCER, DIADENOSINE TRIPHOSPHATE HYDROLASE, HISTIDINE TRIAD, TUMOR SUPPRESSOR
FHIT_HUMAN
UNP
1
1
P49789
MSFRFGQHLIKPSVVFLKTELSFALVNRKPVVPGHVLVCPLRPVERFHDLRPDEVADLFQTTQRVGTVVEKHFHGTSLTF
SMQDGPEAGQTVKHVHVHVLPRKAGDFHRNDSIYEELQKHDKEDFPASWRSEEEMAAEAAALRVYFQ
1
147
1FHI
1
147
P49789
A
1
1
147
5
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
SER
77
A
SER
77
A
MET
82
A
MET
82
A
HIS
96
A
HIS
96
A
ARG
102
A
ARG
102
A
VAL
36
A
VAL
36
A
PRO
40
A
PRO
40
A
SER
22
A
SER
22
A
VAL
26
A
VAL
26
A
VAL
15
A
VAL
15
A
LYS
18
A
LYS
18
HIS 94, HIS 96, HIS 98 THE HISTIDINE TRIAD SITE CONTAINS THE MOTIF COMMON TO PROTEINS IN THE HIT SUPERFAMILY OF NUCLEOTIDE-BINDING PROTEINS. HIS 96 IS THE PRINCIPAL ACTIVE SITE RESIDUE AND SUBSTITUTION WITH ASN REDUCES KCAT (10E6)-FOLD WITH LITTLE EFFECT ON KM. HIS 98 IS PROPOSED TO H-BOND TO THE SCISSILE BRIDGING OXYGEN OF DINUCLEOTIDE SUBSTRATES.
Unknown
3
BINDING SITE FOR RESIDUE IB2 A 301
A
IB2
301
Software
13
A
HIS
94
A
HIS
94
3
1_555
A
HIS
96
A
HIS
96
3
1_555
A
HIS
98
A
HIS
98
3
1_555
A
PHE
5
A
PHE
5
13
1_555
A
ILE
10
A
ILE
10
13
1_555
A
ASN
27
A
ASN
27
13
1_555
A
LEU
37
A
LEU
37
13
1_555
A
THR
79
A
THR
79
13
1_555
A
SER
81
A
SER
81
13
1_555
A
GLN
83
A
GLN
83
13
1_555
A
THR
91
A
THR
91
13
1_555
A
VAL
92
A
VAL
92
13
1_555
A
HIS
96
A
HIS
96
13
1_555
A
HIS
98
A
HIS
98
13
1_555
A
LEU
100
A
LEU
100
13
1_555
A
ARG
102
A
ARG
102
13
1_555
178
P 61 2 2